Emergency Department MRI Scanning of Patients with Multiple Sclerosis: Worthwhile or Wasteful?

References

1. 1.↵
   The National Multiple Sclerosis Society. http://www.nmss.org/. Accessed June 10, 2016.
2. 2.↵
   2. Lublin FD,
   3. Reingold SC

   . Defining the clinical course of multiple sclerosis: results of an international survey—National Multiple Sclerosis Society (USA) Advisory Committee on Clinical Trials of New Agents in Multiple Sclerosis. Neurology 1996;46:907–11 doi:10.1212/WNL.46.4.907 pmid:8780061

   Abstract/FREE Full Text
3. 3.↵
   2. Racke MK

   . Immunopathogenesis of multiple sclerosis. Ann Indian Acad Neurol 2009;12:215–20 doi:10.4103/0972-2327.58274 pmid:20182567

   CrossRefPubMed
4. 4.↵
   2. Compston A,
   3. Coles A

   . Multiple sclerosis. Lancet 2008;372:1502–17 doi:10.1016/S0140-6736(08)61620-7 pmid:18970977

   CrossRefPubMedWeb of Science
5. 5.↵
   2. Lublin FD

   . The incomplete nature of multiple sclerosis relapse resolution. J Neurol Sci 2007;256:S14–18 doi:10.1016/j.jns.2007.01.062 pmid:17337274

   CrossRefPubMed
6. 6.↵
   2. Frohman EM,
   3. Eagar T,
   4. Monson N, et al

   . Immunologic mechanisms of multiple sclerosis. Neuroimaging Clin N Am 2008;18:577–88, ix doi:10.1016/j.nic.2008.06.009 pmid:19068403

   CrossRefPubMedWeb of Science
7. 7.↵
   2. Ontaneda D,
   3. Rae-Grant AD

   . Management of acute exacerbations in multiple sclerosis. Ann Indian Acad Neurol 2009;12:264–72 doi:10.4103/0972-2327.58283 pmid:20182574

   CrossRefPubMed
8. 8.↵
   2. Polman CH,
   3. Reingold SC,
   4. Banwell B, et al

   . Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria. Ann Neurol 2011;69:292–302 doi:10.1002/ana.22366 pmid:21387374

   CrossRefPubMedWeb of Science
9. 9.↵
   2. Repovic P,
   3. Lublin FD

   . Treatment of multiple sclerosis exacerbations. Neurol Clin 2011;29:389–400 doi:10.1016/j.ncl.2010.12.012 pmid:21439448

   CrossRefPubMed
10. 10.↵
    2. Burton JM,
    3. O'Connor PW,
    4. Hohol M, et al

    . Oral versus intravenous steroids for treatment of relapses in multiple sclerosis. Cochrane Database Syst Rev 2012;12:CD006921 doi:10.1002/14651858.CD006921.pub3 pmid:23235634

    CrossRefPubMed
11. 11.↵
    2. Oynhausen S,
    3. Alcauskas M,
    4. Hannigan C, et al

    . Emergency medical care of multiple sclerosis patients: primary data from the Mount Sinai resource utilization in multiple sclerosis project. J Clin Neurol 2014;10:216–21 doi:10.3988/jcn.2014.10.3.216 pmid:25045374

    CrossRefPubMed
12. 12.↵
    2. Arnold DL,
    3. Matthews PM

    . MRI in the diagnosis and management of multiple sclerosis. Neurology 2002;58:S23–31 doi:10.1212/WNL.58.8_suppl_4.S23 pmid:11971123

    Abstract/FREE Full Text
13. 13.↵
    2. Karussis D

    . The diagnosis of multiple sclerosis and the various related demyelinating syndromes: a critical review. J Autoimmun 2014;48–49:134–42 doi:10.1016/j.jaut.2014.01.022 pmid:24524923

    CrossRefPubMed
14. 14.↵
    2. McDonald WI,
    3. Compston A,
    4. Edan G, et al

    . Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the Diagnosis of Multiple Sclerosis. Ann Neurol 2001;50:121–27 doi:10.1002/ana.1032 pmid:11456302

    CrossRefPubMedWeb of Science
15. 15.↵
    2. Bonzano L,
    3. Roccatagliata L,
    4. Mancardi GL, et al

    . Gadolinium-enhancing or active T2 magnetic resonance imaging lesions in multiple sclerosis clinical trials? Mult Scler 2009;15:1043–47 doi:10.1177/1352458509106610 pmid:19570818

    Abstract/FREE Full Text
16. 16.↵
    2. Nusbaum AO,
    3. Lu D,
    4. Tang CY, et al

    . Quantitative diffusion measurements in focal multiple sclerosis lesions: correlations with appearance on TI-weighted MR images. AJR Am J Roentgenol 2000;175:821–25 doi:10.2214/ajr.175.3.1750821 pmid:10954474

    CrossRefPubMedWeb of Science
17. 17.↵
    2. Kornienko VN,
    3. Pronin IN

    . Diagnostic Neuroradiology. Berlin: Springer Berlin; 2009
18. 18.↵
    2. Kermode AG,
    3. Tofts PS,
    4. Thompson AJ, et al

    . Heterogeneity of blood-brain barrier changes in multiple sclerosis: an MRI study with gadolinium-DTPA enhancement. Neurology 1990;40:229–35 doi:10.1212/WNL.40.2.229 pmid:2300240

    Abstract/FREE Full Text
19. 19.↵
    2. Hyland M,
    3. Bermel RA,
    4. Cohen JA

    . Restricted diffusion preceding gadolinium enhancement in large or tumefactive demyelinating lesions. Neurol Clin Pract 2013;3:15–21 doi:10.1212/CPJ.0b013e318283ff8e pmid:23634380

    Abstract/FREE Full Text
20. 20.↵
    2. Redd V,
    3. Levin S,
    4. Toerper M, et al

    . Effects of fully accessible magnetic resonance imaging in the emergency department. Acad Emerg Med 2015;22:741–49 doi:10.1111/acem.12686 pmid:25998846

    CrossRefPubMed
21. 21.↵
    2. Bernstein SL,
    3. Aronsky D,
    4. Duseja R, et al

    ; Society for Academic Emergency Medicine, Emergency Department Crowding Task Force. The effect of emergency department crowding on clinically oriented outcomes. Acad Emerg Med 2009;16:1–10 doi:10.1111/j.1553-2712.2008.00295.x pmid:19007346

    CrossRefPubMedWeb of Science
22. 22.↵
    2. Gardner RL,
    3. Sarkar U,
    4. Maselli JH, et al

    . Factors associated with longer ED lengths of stay. Am J Emerg Med 2007;25:643–50 doi:10.1016/j.ajem.2006.11.037 pmid:17606089

    CrossRefPubMed
23. 23.↵
    2. Kocher KE,
    3. Meurer WJ,
    4. Desmond JS, et al

    . Effect of testing and treatment on emergency department length of stay using a national database. Acad Emerg Med 2012;19:525–34 doi:10.1111/j.1553-2712.2012.01353.x pmid:22594356

    CrossRefPubMedWeb of Science
24. 24.↵
    2. Trzeciak S,
    3. Rivers EP

    . Emergency department overcrowding in the United States: an emerging threat to patient safety and public health. Emerg Med J 2003;20:402–05 doi:10.1136/emj.20.5.402 pmid:12954674

    Abstract/FREE Full Text
25. 25.↵
    Advanced Disease-Specific Care Certification Requirements for Comprehensive Stroke Center (CSC). http://www.jointcommission.org/assets/1/18/dsc_csc_chap.pdf. Accessed May 16, 2016.
26. 26.↵
    2. Thrower BW

    . Relapse management in multiple sclerosis. Neurologist 2009;15:1–5 doi:10.1097/NRL.0b013e31817acf1a pmid:19131851

    CrossRefPubMed
27. 27.↵
    2. Wingerchuk DM,
    3. Rodriguez M

    . Premenstrual multiple sclerosis pseudoexacerbations: role of body temperature and prevention with aspirin. Arch Neurol 2006;63:1005–08 doi:10.1001/archneur.63.7.1005 pmid:16831971

    CrossRefPubMed
28. 28.↵
    American Academy of Pediatrics Committee on Pediatric Emergency Medicine. Overcrowding crisis in our nation's emergency departments: is our safety net unraveling? Pediatrics 2004;114:878–88 doi:10.1542/peds.2004-1287 pmid:15342870

    Abstract/FREE Full Text
29. 29.↵
    2. Derlet RW,
    3. Richards JR

    . Overcrowding in the nation's emergency departments: complex causes and disturbing effects. Ann Emerg Med 2000;35:63–68 doi:10.1016/S0196-0644(00)70105-3 pmid:10613941

    CrossRefPubMedWeb of Science
30. 30.↵
    2. Zwemer FL Jr.

    . Emergency department overcrowding. Ann Emerg Med 2000;36:279–80 pmid:10969243

    PubMed